Literature DB >> 15275326

The plasmodium digestive vacuole: metabolic headquarters and choice drug target.

P L Olliaro1, D E Goldberg.   

Abstract

The Plasmodium digestive (food) vacuole is an acidic proteolytic compartment central to the metabolism of the parasite. Here haemoglobin is degraded, haem is polymerized, amino acid are transported, oxygen radicals are detoxified, drugs are accumulated, acidification is maintained and free iron may be generated. Despite these crucial roles in parasite development, a number of questions about the digestive vacuole and the haemoglobin ingestion pathway remain unanswered; in consequence, a number of attractive drug targets remain to be exploited. Piero Olliaro and Daniel Goldberg here review the morphology, metabolism and pharmacological disruption of this specialized organelle.

Entities:  

Year:  1995        PMID: 15275326     DOI: 10.1016/0169-4758(95)80042-5

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  31 in total

Review 1.  Overcoming the heme paradox: heme toxicity and tolerance in bacterial pathogens.

Authors:  Laura L Anzaldi; Eric P Skaar
Journal:  Infect Immun       Date:  2010-08-02       Impact factor: 3.441

2.  High-Content Screening of the Medicines for Malaria Venture Pathogen Box for Plasmodium falciparum Digestive Vacuole-Disrupting Molecules Reveals Valuable Starting Points for Drug Discovery.

Authors:  Jie Xin Tong; Rajesh Chandramohanadas; Kevin Shyong-Wei Tan
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

3.  Ultrastructural assessment of Plasmodium falciparum in age-fractionated thalassaemic erythrocytes.

Authors:  A C Senok; E A S Nelson; K Li; A R Y Ismaeel; P Olliaro; S J Oppenheimer
Journal:  Parasitol Res       Date:  2005-12-15       Impact factor: 2.289

Review 4.  Ubiquitin-like modifiers and their deconjugating enzymes in medically important parasitic protozoa.

Authors:  Elizabeth L Ponder; Matthew Bogyo
Journal:  Eukaryot Cell       Date:  2007-09-28

5.  Optimization of xanthones for antimalarial activity: the 3,6-bis-omega-diethylaminoalkoxyxanthone series.

Authors:  Jane Xu Kelly; Rolf Winter; David H Peyton; David J Hinrichs; Michael Riscoe
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

6.  Inhibition of hemozoin formation in Plasmodium falciparum trophozoite extracts by heme analogs: possible implication in the resistance to malaria conferred by the beta-thalassemia trait.

Authors:  J A Martiney; A Cerami; A F Slater
Journal:  Mol Med       Date:  1996-03       Impact factor: 6.354

Review 7.  Malarial hemozoin: from target to tool.

Authors:  Lorena M Coronado; Christopher T Nadovich; Carmenza Spadafora
Journal:  Biochim Biophys Acta       Date:  2014-02-17

8.  Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum.

Authors:  A M Silva; A Y Lee; S V Gulnik; P Maier; J Collins; T N Bhat; P J Collins; R E Cachau; K E Luker; I Y Gluzman; S E Francis; A Oksman; D E Goldberg; J W Erickson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

9.  Discovery of dual function acridones as a new antimalarial chemotype.

Authors:  Jane X Kelly; Martin J Smilkstein; Reto Brun; Sergio Wittlin; Roland A Cooper; Kristin D Lane; Aaron Janowsky; Robert A Johnson; Rozalia A Dodean; Rolf Winter; David J Hinrichs; Michael K Riscoe
Journal:  Nature       Date:  2009-04-08       Impact factor: 49.962

10.  Plasmodium falciparum enolase: stage-specific expression and sub-cellular localization.

Authors:  Ipsita Pal Bhowmick; Nirbhay Kumar; Shobhona Sharma; Isabelle Coppens; Gotam K Jarori
Journal:  Malar J       Date:  2009-07-30       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.